Anti-major histocompatibility complex class II treatment prevents graft rejectionin the hamster-to-rat cardiac xenograft

Transplantation

Volumn 67, Issue 12, 1999, Pages 1599-1606

  Saxton, Nina E ^a,b   Hallaway, Rhona V ^a   Ladyman, Heather M ^a   Janczynski, Barbara T ^a   Nesbitt, Andrew M ^a   Zinkewich Peotti, Karen ^a   Smith, Richard ^c   Foulkes, Roland ^a  

^a UCB PHARMA   (Belgium)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIBODY; CYCLOSPORIN A; IMMUNOGLOBULIN M; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTER; GRAFT REJECTION; GRAFT SURVIVAL; HAMSTER; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RAT; XENOGRAFT;

ANIMALS; ANTIBODIES; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELL SEPARATION; CRICETINAE; CYCLOSPORINE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES; MALE; MESOCRICETUS; RATS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033050203     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199906270-00015     Document Type: Article

References (24)

1. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach. FH. Immunopathology of hyperacute rejection in a swine-to-primate model. Transplantation. 1991; 52: 214.
2. Calne RY. Organ transplantation between widely disparate species. Transpl Proc 1970; 2: 550.
3. Hasan R., Van den Bogaerde JB, Wallwork J, White DJG. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation. 1992; 54(3): 408.
4. Nielsen B, Steinbruchel DA, Lillevang ST, Salomon S, Kemp E. Natural history of hamster heart rejected when transplanted to rat: a pathoanatomical study including immunohistochemistry. Transplant Proc 1994; 26(2): 1024.
5. Wang J, Morris RE. Effect of splenectomy and mono or combination therapy with rapamycin, the morpholinoethylester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival. Transplant Proc 1991; 23: 699.
6. Murase N, Demetris AJ, Tanabe M, et al. Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat. Transplant Proc 1993; 25(1 Pt 1): 425.
7. Steinbruchel DA. Pathogenesis and mechanisms of graft rejection in concordant xenotransplantation with special reference to hamster-to-rat cardiac transplantation. APMIS Suppl. 1996; 58(104): 5.
8. Braidley P, Aravot D, Hunter S, Dunning J, White D, Wallwork J. Transgenic pigs: breakthrough in xenotransplantation. Israel. J Med Sci 1996; 32: 795.
9. Waterworth PD, Cozzi E, Tolan MJ, et al. Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy. Transpl Proc 1997; 29: 899.
10. Scholl PR, Geha RS. MHC class II signalling in B-cell activation. Immunol Today 1994:15 (9): 418.
11. Bonagura VR, Agostino N, Crow MK, Pernis B. Anti-immunoglobulin stimulation of human B lymphocytes is inhibited by anti-class II histocompatibility complex antibodies. Cell Immunol 1985; 96: 442.
12. Priestley CA, Spencer SC, Sawyer GJ, Fabre JW. Suppression of kidney allograft rejection across full MHC barriers by recipient-specific antibodies to class II MHC antigens. Transplantation. 1992; 53(5): 1024.
13. Smith RM, Morgan A, Wraith DC. Anti-MHC class II antibodies prevent and treat EAE without APC depletion. Immunology 1994; 83: 1.
14. Smith RM, Chen ZK, Foulkes R, Metcalfe SM, Wraith DC. Prolongation of murine vascularised heart allograft survival by recipient-specific anti-major histocompatibility complex class II antibody. Transplantation. 1997; 64(3): 525.
15. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thoracic Cardiovasc Surg 1969; 57: 225.
16. Fukumoto T, McMaster WR, Williams AF. Mouse monoclonal antibodies against rat histocompatibility antigens: two Ia antigens and expression of Ia antigens and class I antigens in rat thymus. Eur J Immunol 1982; 12: 237.
17. Langer A, Valdivia LA, Murase N, et al. Humoral and cellular immunopathology of hepatic and cardiac hamster-to-rat xenograft rejection. Marked stimulation of IgM++ bright/IgD+ dull splenic B cells. Am J Pathol 1993; 143: 85.
18. Sheffield CD, Hadley GA, Dirden BM, Bartlett MD. Prolonged cardiac xenograft survival is induced by intrathymic splenocyte injection. J Surg Res 1994; 57: 55.
19. Lin Y, Vandeputte M, Waer M. Difference in tolerisation of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats. Transpl Proc 1996; 28(2): 741.
20. Waldor MK, Hardy RR, Hayakawa K, Steinman L, Herzenberg LA, Herzenberg LA. Disappearance and reappearance of B-cells after in vivo treatment with monoclonal anti-I-A antibodies. Proc Natl Acad Sci 1984; 81: 2855.
21. Rosenbaum JT, Adelman NE, McDevitt HO. In vivo effects of antibodies to immune response gene product: I. Haplotype specific suppression of humoral immune responses with a monoclonal anti-I-A. J Exp Med 1981; 154: 1694.
22. Tanaka Y, Shirakawa F, Ota, T, Suzuki H, Eto S, Yamashita U. Inhibitory effect of anti-class II antibodies on human B-cell activation. Cell Immunol 1988; 112: 251.
23. Forsgren S, Martinez-AC, Coutinho A. The role of I-A/E molecules in B-lymphocyte activation. II. Mechanism of inhibition of the responses to lipopolysaccharide by anti-I-A/E antibodies. Scand J Immunol 1987; 25(3): 225.
24. Andre P, Cambier JC, Wade TK, Raetz T, Wade WF. Distinct structural compartmentalisation of the signal transducing functions of major histocompatibility class II (Ia) molecules. J Exp Med 1994; 179: 763.